Dr. George P. Christophi, MD, PhD

Dr. Christophi practices at Steward Medical Group, Inc. in Rockledge, Florida.

Dr. Christophi's NPI, 1174818058, was assigned on June 18, 2011. Dr. Christophi holds Missouri license 2013002768.

Dr. Christophi's primary practice is Steward Medical Group, Inc., at 111 Longwood Ave, Rockledge, FL 32955 in Brevard County. The practice phone is (615) 467-4158.

Dr. Christophi's primary practice is Steward Medical Group, Inc. in Rockledge, Florida. Dr. Christophi is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Christophi to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Christophi practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Christophi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Christophi is licensed in Missouri.

CMS data shows 1,658 Medicare services from Dr. Christophi across 17 procedure codes in 2024, for 753 Medicare patients. Medicare paid $182,694 for them.

CMS counts 753 Medicare patients who saw Dr. Christophi in 2024. The largest group is 65 to 74, with 374 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Christophi's median patient age at 64, with 58% women.

In 2024, Dr. Christophi wrote 5,275 Medicare Part D claims for 1,570 patients. 88% of them were for generic drugs. CMS names the drug for 5,005 of them, across 47 drugs with 11 or more claims each, at $2,976,468 in total drug cost. In 2023, CMS named 4,605 claims across 55 drugs.

Dr. Christophi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Christophi as offering telehealth. CMS counts 236 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Christophi, more than 92% of the clinicians it reports for that procedure.

Dmand AI links Dr. Christophi to 1 clinical trial. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases. Open Payments lists research payments to Dr. Christophi that name 1 trial.

CMS Open Payments shows 197 general payments to Dr. Christophi from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $1,760. It also lists 1 research payment totaling $6,123 in 2018, naming 1 clinical trial.